Ritchy Hodebourg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ritchy Hodebourg has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Peter W. Kalivas
Department of Neuroscience, Medical University of South Carolina, Charleston, SC
4 shared publications Eric Dereschewitz
Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA
2 shared publicationsLillian Duncan
Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA
2 shared publicationsAna-Clara Bobadilla
Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina; School of Pharmacy, University of Wyoming, Laramie, Wyoming
1 shared publicationAnna Kruyer
Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina
1 shared publication- Ariana Angelis
Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA
1 shared publication
Latest Publications
- Open Access
- 11 June 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (10) , 5979-5992
Cannabinoid use generalizes stress responses: involvement of astrocyte plasticity and activation of matrix metalloproteinases in the nucleus accumbens core
The rising legal acceptance of cannabis and the high comorbidity between cannabis use disorder (CUD) and post-traumatic stress disorder (PTSD) highlight the importance of understanding how stress and cannabis influence the brain. We recently discovered that cannabinoid use promotes two PTSD-like symptoms: avoidance coping behaviors and the generalization of stress-coping responses to a neutral stimulus. Here, we used in vivo zymography and confocal microscopy to examine how stress and cannabinoid use influence multipartite synaptic plasticity. Specifically, we assessed astroglial plasticity, Synapsin-I density, and matrix metalloproteinases (MMP-2,9) activity, in the nucleus accumbens core (NAcore). For this purpose, rats were restrained for 2 h and simultaneously exposed to an odor; the stress-conditioned stimulus (stress-CS). Three weeks later, rats were exposed to cannabinoid vapor (delta9-tetrahydrocannabinol+cannabidiol; THC + CBD) for 5 days, self-administered THC + CBD (i.v.) for 10 days, followed by 10 days of abstinence. We then evaluated the effect of stress-CS or neutral odor (NS) on coping strategies in a defensive burying task. We found that THC + CBD generalized stress responses to the NS, associated with astrocyte retraction from synapses and a decrease in Synapsin-I density. THC + CBD pretreatment promoted avoidant coping during stress-CS exposure, activated MMP-2,9, re-associated astrocytes with synapses, increased Synapsin-I density, and caused astrocyte atrophy. By inhibiting MMP-2,9, we found that stress-CS-induced plasticity required MMP-2,9 activation. MMP-2 inhibition also restored active coping behaviors during stress-CS exposure. Surprisingly, these neuroadaptations only occurred in males. Overall, these findings suggest a potential role for MMPs and astrocytes in the changes produced by THC + CBD use in responding to a stress-CS.
- 11 June 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (10) , 5979-5992
Open AccessCannabinoid use generalizes stress responses: involvement of astrocyte plasticity and activation of matrix metalloproteinases in the nucleus accumbens core
The rising legal acceptance of cannabis and the high comorbidity between cannabis use disorder (CUD) and post-traumatic stress disorder (PTSD) highlight the importance of understanding how stress and cannabis influence the brain. We recently discovered that cannabinoid use promotes two PTSD-like symptoms: avoidance coping behaviors and the generalization of stress-coping responses to a neutral stimulus. Here, we used in vivo zymography and confocal microscopy to examine how stress and cannabinoid use influence multipartite synaptic plasticity. Specifically, we assessed astroglial plasticity, Synapsin-I density, and matrix metalloproteinases (MMP-2,9) activity, in the nucleus accumbens core (NAcore). For this purpose, rats were restrained for 2 h and simultaneously exposed to an odor; the stress-conditioned stimulus (stress-CS). Three weeks later, rats were exposed to cannabinoid vapor (delta9-tetrahydrocannabinol+cannabidiol; THC + CBD) for 5 days, self-administered THC + CBD (i.v.) for 10 days, followed by 10 days of abstinence. We then evaluated the effect of stress-CS or neutral odor (NS) on coping strategies in a defensive burying task. We found that THC + CBD generalized stress responses to the NS, associated with astrocyte retraction from synapses and a decrease in Synapsin-I density. THC + CBD pretreatment promoted avoidant coping during stress-CS exposure, activated MMP-2,9, re-associated astrocytes with synapses, increased Synapsin-I density, and caused astrocyte atrophy. By inhibiting MMP-2,9, we found that stress-CS-induced plasticity required MMP-2,9 activation. MMP-2 inhibition also restored active coping behaviors during stress-CS exposure. Surprisingly, these neuroadaptations only occurred in males. Overall, these findings suggest a potential role for MMPs and astrocytes in the changes produced by THC + CBD use in responding to a stress-CS.
- Open Access
- 21 August 2025
- Published by Springer Nature in Research Square
Cannabinoid use generalizes stress responses by altering the astrocyte plasticity through extracellular matrix signaling in the nucleus accumbens core
The rising legal acceptance of cannabis and the high comorbidity between cannabis use disorder (CUD) and post-traumatic stress disorder (PTSD) highlight the importance of understanding how stress and cannabis influence the brain. We recently discovered that cannabis use promotes two PTSD-like symptoms: avoidance coping behaviors and the generalization of stress-coping responses to a neutral stimulus not previously linked to stress. To investigate the neuroadaptations behind these changes, we used in vivo zymography and confocal microscopy to examine how stress and cannabinoid use influence multipartite synaptic plasticity in the nucleus accumbens core (NAcore), including astroglial plasticity, Synapsin-I density, and matrix metalloproteinases (MMP-2,9) activity. For this purpose, rats were restraint stressed for 2h and simultaneously exposed to an odor that became the stress-conditioned stimulus (stress-CS). Three weeks later, rats self-administered cannabinoids (delta9-tetrahydrocannabinol + cannabidiol; THC + CBD) for 10 days, followed by 10 days of withdrawal. We then evaluated the effect of stress-CS or neutral odor (NS) on coping strategies in a defensive burying task. We demonstrated for the first time that THC + CBD generalized stress responses to the NS by causing astrocytes to retract from synapses and decreasing Synapsin-I density in the NAcore. Furthermore, cannabinoid use promoted avoidant coping behaviors in response to a stress-CS by triggering strong activation of MMP-2,9, driven largely by MMP-2, causing a re-association of astrocytes to synapses along with an increase of Synapsin-I density and astrocyte atrophy. However, these neuroadaptations only occurred in males. Overall, these findings highlight potential therapeutic targets like MMPs and astrocytes for treating co-occurring CUD/PTSD.
- 21 August 2025
- Published by Springer Nature in Research Square
Open AccessCannabinoid use generalizes stress responses by altering the astrocyte plasticity through extracellular matrix signaling in the nucleus accumbens core
The rising legal acceptance of cannabis and the high comorbidity between cannabis use disorder (CUD) and post-traumatic stress disorder (PTSD) highlight the importance of understanding how stress and cannabis influence the brain. We recently discovered that cannabis use promotes two PTSD-like symptoms: avoidance coping behaviors and the generalization of stress-coping responses to a neutral stimulus not previously linked to stress. To investigate the neuroadaptations behind these changes, we used in vivo zymography and confocal microscopy to examine how stress and cannabinoid use influence multipartite synaptic plasticity in the nucleus accumbens core (NAcore), including astroglial plasticity, Synapsin-I density, and matrix metalloproteinases (MMP-2,9) activity. For this purpose, rats were restraint stressed for 2h and simultaneously exposed to an odor that became the stress-conditioned stimulus (stress-CS). Three weeks later, rats self-administered cannabinoids (delta9-tetrahydrocannabinol + cannabidiol; THC + CBD) for 10 days, followed by 10 days of withdrawal. We then evaluated the effect of stress-CS or neutral odor (NS) on coping strategies in a defensive burying task. We demonstrated for the first time that THC + CBD generalized stress responses to the NS by causing astrocytes to retract from synapses and decreasing Synapsin-I density in the NAcore. Furthermore, cannabinoid use promoted avoidant coping behaviors in response to a stress-CS by triggering strong activation of MMP-2,9, driven largely by MMP-2, causing a re-association of astrocytes to synapses along with an increase of Synapsin-I density and astrocyte atrophy. However, these neuroadaptations only occurred in males. Overall, these findings highlight potential therapeutic targets like MMPs and astrocytes for treating co-occurring CUD/PTSD.
- 23 April 2025
- Published by Springer Nature
- Vol. 2918, 21-33
In Vivo Zymography: An Essential Activity Assay for Studying the Activity of Matrix Metalloproteinases in Specific Brain Cells
Matrix metalloproteinases (MMPs) are a group of zinc endopeptidases that break down the extracellular matrix. MMP-2 and MMP-9 are particularly abundant in the brain and are essential for synaptic plasticity. When studying synaptic plasticity, it is crucial to measure their activity in both normal and pathological conditions. Although gel and in situ zymography are commonly used to assess MMP proteolytic activity, these methods are typically applied to samples and tissues ex vivo and do not allow the quantification of MMP function during a behavioral experiment. Consequently, the in vivo zymography represents the ideal activity assay to study the MMP function. Moreover, we recently developed a method to quantify MMP activity in specific cell types in rat brains. This chapter details the in vivo zymography approach used to accurately quantify the gelatinolytic activity of MMP-2 and MMP-9 in rat brains in both non-cell-specific and cell-specific manners.
- 23 April 2025
- Published by Springer Nature
- Vol. 2918, 21-33
In Vivo Zymography: An Essential Activity Assay for Studying the Activity of Matrix Metalloproteinases in Specific Brain Cells
Matrix metalloproteinases (MMPs) are a group of zinc endopeptidases that break down the extracellular matrix. MMP-2 and MMP-9 are particularly abundant in the brain and are essential for synaptic plasticity. When studying synaptic plasticity, it is crucial to measure their activity in both normal and pathological conditions. Although gel and in situ zymography are commonly used to assess MMP proteolytic activity, these methods are typically applied to samples and tissues ex vivo and do not allow the quantification of MMP function during a behavioral experiment. Consequently, the in vivo zymography represents the ideal activity assay to study the MMP function. Moreover, we recently developed a method to quantify MMP activity in specific cell types in rat brains. This chapter details the in vivo zymography approach used to accurately quantify the gelatinolytic activity of MMP-2 and MMP-9 in rat brains in both non-cell-specific and cell-specific manners.
- Open Access
Matrix Metalloproteinase Activity During Methamphetamine Cued Relapse
Relapse to drug seeking involves transient synaptic remodeling that occurs in response to drug associated cues. This remodeling includes activation of matrix metalloproteinases (MMPs) to initiate catalytic signaling in the extracellular matrix (ECM) in the nucleus accumbens core (NAcore). We hypothesized that MMP activity would be increased in the NAcore during cue-induced methamphetamine (meth) seeking in a rat model of meth use and relapse. Male and female rats had indwelling jugular catheters and bilateral intracranial cannula targeting the NAcore surgically implanted. Following recovery, rats underwent meth or saline self-administration (6hr/day for 15 days) in which active lever responding was paired with a light+tone stimulus complex, followed by home cage abstinence. Testing occurred after 7 or 30 days of abstinence. On test day, rats were microinjected with a FITC-quenched gelatin substrate that fluoresces following cleavage by MMPs, allowing for the quantification of gelatinase activity by MMP-2 and −9 during cued relapse testing. MMP-2,9 activity was significantly increased in the NAcore by meth cues presentation after 7 and 30 days of abstinence, indicating that remodeling by MMPs occurs during presentation of meth associated cues. Surprisingly, while cue-induced seeking increased between days 7 and 30, suggesting behavioral incubation, MMP-2,9 activity did not increase. These findings indicate that while MMP activation is elicited during meth cue-induced seeking, MMP activation did not parallel the behavioral incubation that occurs during extended drug abstinence.
Open AccessMatrix Metalloproteinase Activity During Methamphetamine Cued Relapse
Relapse to drug seeking involves transient synaptic remodeling that occurs in response to drug associated cues. This remodeling includes activation of matrix metalloproteinases (MMPs) to initiate catalytic signaling in the extracellular matrix (ECM) in the nucleus accumbens core (NAcore). We hypothesized that MMP activity would be increased in the NAcore during cue-induced methamphetamine (meth) seeking in a rat model of meth use and relapse. Male and female rats had indwelling jugular catheters and bilateral intracranial cannula targeting the NAcore surgically implanted. Following recovery, rats underwent meth or saline self-administration (6hr/day for 15 days) in which active lever responding was paired with a light+tone stimulus complex, followed by home cage abstinence. Testing occurred after 7 or 30 days of abstinence. On test day, rats were microinjected with a FITC-quenched gelatin substrate that fluoresces following cleavage by MMPs, allowing for the quantification of gelatinase activity by MMP-2 and −9 during cued relapse testing. MMP-2,9 activity was significantly increased in the NAcore by meth cues presentation after 7 and 30 days of abstinence, indicating that remodeling by MMPs occurs during presentation of meth associated cues. Surprisingly, while cue-induced seeking increased between days 7 and 30, suggesting behavioral incubation, MMP-2,9 activity did not increase. These findings indicate that while MMP activation is elicited during meth cue-induced seeking, MMP activation did not parallel the behavioral incubation that occurs during extended drug abstinence.
- 9 December 2020
- Published by Elsevier in Biological Psychiatry
- Vol. 89 (10) , 947-958
Heroin Seeking and Extinction From Seeking Activate Matrix Metalloproteinases at Synapses on Distinct Subpopulations of Accumbens Cells
- 9 December 2020
- Published by Elsevier in Biological Psychiatry
- Vol. 89 (10) , 947-958
Heroin Seeking and Extinction From Seeking Activate Matrix Metalloproteinases at Synapses on Distinct Subpopulations of Accumbens Cells
- 3 December 2020
- Published by Springer Nature
- p. 199-208
Intracranial Self-Stimulation: Using the Curve-Shift Paradigm to Assess the Abuse Potential of Drugs
- 3 December 2020
- Published by Springer Nature
- p. 199-208
Intracranial Self-Stimulation: Using the Curve-Shift Paradigm to Assess the Abuse Potential of Drugs